These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4981689)

  • 1. Purification of the first component of complement by zonal ultracentrifugation.
    Colten HR; Bond HE; Borsos T; Rapp HJ
    J Immunol; 1969 Oct; 103(4):862-5. PubMed ID: 4981689
    [No Abstract]   [Full Text] [Related]  

  • 2. [A method for the specific purification of the first complement component C1].
    Wunderlich R; Ringelmann R
    Med Microbiol Immunol; 1972; 157(2):120-31. PubMed ID: 5063560
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation and purification of the fourth component of guinea-pig complement.
    Chan PC; Cebra JJ
    Immunochemistry; 1968 Jan; 5(1):17-22. PubMed ID: 5647092
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the third component (C'3) of guinea pig complement. I. Purification and characterization.
    Yonematsu K; Inoue K
    Biken J; 1968 Sep; 11(3):169-80. PubMed ID: 4976235
    [No Abstract]   [Full Text] [Related]  

  • 5. A specific method for purification of the second component of guinea pig complement and a chemical evaluation of the one-hit theory.
    Mayer MM; Miller JA; Shin HS
    J Immunol; 1970 Aug; 105(2):327-41. PubMed ID: 5433696
    [No Abstract]   [Full Text] [Related]  

  • 6. A simple method for the isolation of the subcomponents of the first component of complement by affinity chromatography.
    Assimeh SN; Bing DH; Painter RH
    J Immunol; 1974 Jul; 113(1):225-34. PubMed ID: 4857625
    [No Abstract]   [Full Text] [Related]  

  • 7. Rat 7S immunoglobulins: characterization of gamma-2- and gamma-1-anti-haptens antibodies.
    Jones VE
    Immunology; 1969 May; 16(5):589-99. PubMed ID: 4977835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The purification and reactivity of the first component of complement from guinea pig, human and canine sera.
    Tamura N; Nelson RA
    J Immunol; 1968 Dec; 101(6):1333-45. PubMed ID: 4972623
    [No Abstract]   [Full Text] [Related]  

  • 9. A functional abnormality of the fifth component of complement (C5) from human serum of individuals with a familial opsonic defect.
    Nilsson UR; Miller ME; Wyman S
    J Immunol; 1974 Mar; 112(3):1164-76. PubMed ID: 4204560
    [No Abstract]   [Full Text] [Related]  

  • 10. The ninth component of guinea-pig complement. Isolation and identification as an alpha 2-globulin.
    Tamura N; Shimada A
    Immunology; 1971 Mar; 20(3):415-25. PubMed ID: 4101489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q.
    Volanakis JE; Kaplan MH
    J Immunol; 1974 Jul; 113(1):9-17. PubMed ID: 4208926
    [No Abstract]   [Full Text] [Related]  

  • 12. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
    Ballow M; Cochrane CG
    J Immunol; 1969 Nov; 103(5):944-52. PubMed ID: 4981797
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation of the sixth component of complement from human serum.
    Arroyave CM; Müller-Eberhard HJ
    Immunochemistry; 1971 Nov; 8(11):995-1006. PubMed ID: 4110102
    [No Abstract]   [Full Text] [Related]  

  • 14. C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.
    Ruddy S; Austen KF
    J Immunol; 1971 Sep; 107(3):742-50. PubMed ID: 4999095
    [No Abstract]   [Full Text] [Related]  

  • 15. [Purification of Australia- SH antigen for production of antibodies in experimental animals].
    Schober A; Kaboth U; Thomssen R
    Z Med Mikrobiol Immunol; 1971; 156(3):250-8. PubMed ID: 4998023
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of the lytic effect of guinea pig complement by rabbit complement.
    Kempf RA; Gigli I; Austen KF
    J Immunol; 1969 Apr; 102(4):795-803. PubMed ID: 5768190
    [No Abstract]   [Full Text] [Related]  

  • 17. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
    Ruddy S; Austen KF
    J Immunol; 1969 Mar; 102(3):533-43. PubMed ID: 5813010
    [No Abstract]   [Full Text] [Related]  

  • 18. A new immunochemical assay for the detection of the first component of complement C1.
    Colten HR; Spalter JS
    J Immunol; 1970 May; 104(5):1043-7. PubMed ID: 5444335
    [No Abstract]   [Full Text] [Related]  

  • 19. [A simple method of a standard determination for the complement activity].
    Schumann G; Müller HL
    Z Immunitatsforsch Exp Klin Immunol; 1971; 141(3):201-10. PubMed ID: 4251863
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations on the mechanism of immune hemolysis: importance of immunoglobulin class and source of complement on the extent of damage.
    Frank MM; Dourmashkin RR; Humphrey JH
    J Immunol; 1970 Jun; 104(6):1502-10. PubMed ID: 5452415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.